BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 26718971)

  • 1. The pathogenesis and treatment of cardiac atrophy in cancer cachexia.
    Murphy KT
    Am J Physiol Heart Circ Physiol; 2016 Feb; 310(4):H466-77. PubMed ID: 26718971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How progressive cancer endangers the heart: an intriguing and underestimated problem.
    Ausoni S; Calamelli S; Saccà S; Azzarello G
    Cancer Metastasis Rev; 2020 Jun; 39(2):535-552. PubMed ID: 32152913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardio-oncology - elucidation of the mechanism of cardiac dysfunction caused by cancer therapy and cancer cachexia].
    Nonaka M; Ueno S; Uezono Y
    Nihon Yakurigaku Zasshi; 2020; 155(3):165-170. PubMed ID: 32378637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac alterations in cancer-induced cachexia in mice.
    Tian M; Nishijima Y; Asp ML; Stout MB; Reiser PJ; Belury MA
    Int J Oncol; 2010 Aug; 37(2):347-53. PubMed ID: 20596662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-induced cardiac cachexia: Pathogenesis and impact of physical activity (Review).
    Belloum Y; Rannou-Bekono F; Favier FB
    Oncol Rep; 2017 May; 37(5):2543-2552. PubMed ID: 28393216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes in the pathogenesis and treatment of cancer-related cachexia.
    Ru Q; Chen L; Xu G; Wu Y
    J Transl Med; 2024 Apr; 22(1):408. PubMed ID: 38689293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for cardiac atrophic remodeling in cancer-induced cachexia in mice.
    Tian M; Asp ML; Nishijima Y; Belury MA
    Int J Oncol; 2011 Nov; 39(5):1321-6. PubMed ID: 21822537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?
    Mueller TC; Bachmann J; Prokopchuk O; Friess H; Martignoni ME
    BMC Cancer; 2016 Feb; 16():75. PubMed ID: 26856534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Remodeling in Cancer-Induced Cachexia: Functional, Structural, and Metabolic Contributors.
    Wiggs MP; Beaudry AG; Law ML
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerobic exercise training as therapy for cardiac and cancer cachexia.
    Alves CR; da Cunha TF; da Paixão NA; Brum PC
    Life Sci; 2015 Mar; 125():9-14. PubMed ID: 25500304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of cancer cachexia‑induced muscle atrophy (Review).
    Yang W; Huang J; Wu H; Wang Y; Du Z; Ling Y; Wang W; Wu Q; Gao W
    Mol Med Rep; 2020 Dec; 22(6):4967-4980. PubMed ID: 33174001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmuscle Tissues Contribution to Cancer Cachexia.
    Argilés JM; Stemmler B; López-Soriano FJ; Busquets S
    Mediators Inflamm; 2015; 2015():182872. PubMed ID: 26523094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise training delays cardiac remodeling in a mouse model of cancer cachexia.
    Fernandes LG; Tobias GC; Paixão AO; Dourado PM; Voltarelli VA; Brum PC
    Life Sci; 2020 Nov; 260():118392. PubMed ID: 32898523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer cachexia, recent advances, and future directions.
    Penet MF; Bhujwalla ZM
    Cancer J; 2015; 21(2):117-22. PubMed ID: 25815852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On our way to targeted therapy for cachexia in cancer?
    Boddaert MS; Gerritsen WR; Pinedo HM
    Curr Opin Oncol; 2006 Jul; 18(4):335-40. PubMed ID: 16721127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle regeneration in cancer cachexia.
    Bossola M; Marzetti E; Rosa F; Pacelli F
    Clin Exp Pharmacol Physiol; 2016 May; 43(5):522-7. PubMed ID: 26857538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac Complications: The Understudied Aspect of Cancer Cachexia.
    Bora V; Patel B
    Cardiovasc Toxicol; 2022 Mar; 22(3):254-267. PubMed ID: 35171467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withaferin A attenuates ovarian cancer-induced cardiac cachexia.
    Kelm NQ; Straughn AR; Kakar SS
    PLoS One; 2020; 15(7):e0236680. PubMed ID: 32722688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of peripheral muscle wasting in cardiac cachexia.
    Filippatos GS; Anker SD; Kremastinos DT
    Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):249-54. PubMed ID: 15809526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathophysiology of cancer-mediated cardiac cachexia and novel treatment strategies: A narrative review.
    Tichy L; Parry TL
    Cancer Med; 2023 Sep; 12(17):17706-17717. PubMed ID: 37654192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.